Newly curated references since 2025-12-01 |
|---|
| Reference | Species | Genes Addressed |
|---|
Barker KS, et al. (2025) Relative contributions of the ERG11(VF125AL) and MRR1A(N647T) mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates. Clin Microbiol Infect
  | C. auris | |ERG11 |MDR1 |MRR1 |TAC1b |
Denning-Jannace CA, et al. (2025) Leveraging Vulnerabilities in Copper Trafficking for Synergistic Antifungal Activity. ACS Chem Biol
| C. albicans | |ADH1 |ATP1 |ATP2 |ATX1 |CCC2 |CRD2 |CYC1 |FET34 |GOR1 |GST2 |PDC11 |PST3 |SOD1 |SOD3 |MORE |
Feng J, et al. (2025) Dietary tannic acid promotes intestinal clearance of C. albicans by cross-linking hyphal chitosan. PLoS Pathog 21(10):e1013596
| C. albicans | |ALS2 |CDA2 |CHS1 |CHS2 |CHS3 |CHS5 |CHS7 |CHS8 |CHT1 |CHT2 |CHT4 |CSH1 |PGA13 |
Fu C, et al. (2025) Expansion of the functional genomics GRACE library reveals genes relevant for temperature-dependent fitness in Candida albicans. PLoS Biol 23(10):e3003409
| C. albicans | |GAR1 |RHT1 |YSF3 |
Gao H, et al. (2025) An Ultrasensitive Nucleic Acid Detection Platform Based on Phosphorothioate-DNA. ACS Sens
| C. albicans | |ERG11 |
Gao Z, et al. (2025) Design, synthesis, and antifungal activity of novel amide imidazole CYP51 inhibitors with aromatic fused ring hydrophobic side chains. RSC Med Chem
| C. albicans | |ERG11 |
Hoseinnejad A, et al. (2025) Is there a difference in the expression levels of genes responsible for fluconazole resistance in Candida albicans isolated from people with different underlying diseases? A systematic review. Curr Med Mycol 11
| C. albicans | |CDR1 |CDR2 |ERG11 |ERG3 |IFD6 |IFU5 |MDR1 |PMA1 |RTA2 |
Jara M, et al. (2025) Genomic Dynamics of the Emergent Candida auris: Exploring Climate-dependent Trends. Open Forum Infect Dis 12(10):ofaf441
| C. auris | |HSP104 |HSP90 |
Jiang J, et al. (2025) Molecular landscape of the fungal plasma membrane and implications for antifungal action. Nat Commun 16(1):9125
| C. glabrata | |AQY1 |FEN1 |FKS1 |FKS2 |INP53 |OSH2 |PMA1 |RHO1 |
Jin HW and Eom YB (2025) Biochanin A Suppresses Growth and Biofilm Formation of Fluconazole-Resistant Candida auris. Curr Microbiol 82(12):591
| C. auris | |ERG11 |KRE6 |
Kauser S, et al. (2025) Exploring fungal survival mechanisms: toward next-generation antifungal therapies against Candida spp. Arch Microbiol 207(11):302
| C. albicans | |ADR1 |ALS3 |BCK1 |CCH1 |CDC10 |CDC11 |CDC12 |CDC3 |CDC37 |CDC42 |CEK1 |CEK2 |CHK1 |CPH1 |MORE |
Laaboudi FZ, et al. (2025) In Vitro Exposure to Vaped Tetrahydrocannabinol Increases Candida albicans (SC5314) Growth, Metabolic Activity, Biofilm Formation, and the Expression of Virulence Genes. Microorganisms 13(10)
| C. albicans | |EAP1 |SAP2 |SAP4 |SAP9 |
Li S, et al. (2025) Study on the impact of biofilm formation by Candida albicans in recurrent vulvovaginal candidiasis on drug susceptibility. Front Cell Infect Microbiol 15:1663099
| C. albicans | |CDR1 |CDR2 |MDR1 |
Liu H, et al. (2025) Airway Candida diversity in COPD patients and its differential stimulatory effects on lung inflammation in mice. BMC Pulm Med 25(1):495
| C. parapsilosis | |ITS1 |
| C. dubliniensis | |ITS1 |
| C. albicans | |ITS1 |
| C. glabrata | |ITS1 |
Mahmoodi M, et al. (2025) Investigating the presence of phospholipase and secreted aspartyle proteinase gene family in different genotypes of Candida albicans species. BMC Res Notes 18(1):431
| C. albicans | |PLB1 |PLB2 |SAP1 |SAP2 |SAP3 |SAP4 |SAP5 |SAP6 |SAP7 |SAP8 |
Manerkar M, et al. (2025) Effects of silver diamine fluoride on oral bacteriome and mycobiome: a randomized clinical trial. BMC Oral Health 25(1):1643
| C. dubliniensis | |ITS1 |
Ragozzino S, et al. (2025) bueMicroRNA whole-blood profiling in hospitalized patients with candidemia identified miR-125a-5p and miR-99b-5p as potential biomarkers for Candida albicans bloodstream infection. Int J Infect Dis :108148
|
Tavares ER, et al. (2025) Development of Melting-Curve-Based Real-Time PCR for Differentiating Medically Important Candida Species. Int J Mol Sci 26(19)
| C. parapsilosis | |ITS1 |
| C. albicans | |ITS1 |
| C. glabrata | |ITS1 |
| C. auris | |ITS1 |
Valencia C, et al. (2025) Modeling heterogeneity in single-cell perturbation states enhances detection of response eQTLs. Nat Genet
| C. albicans | |RPS26A |
Vera-Salazar LA, et al. (2025) Abf1 participates in the response to DNA damage and replicative stress in Candida glabrata (Nakaseomyces glabratus). Fungal Genet Biol :104041
| C. glabrata | |ABF1 |
Xin H (2025) Advancing Peptide-Based Vaccines Against Candida: A Comparative Perspective on Liposomal and Synthetic Formulations. J Fungi (Basel) 11(10)
| C. auris | |FBA1 |MET6 |
Yan C, et al. (2025) Virulence factors, biofilm formation and antifungal resistance in Candida albicans from recurrent vulvovaginal candidiasis patients: a comparative study. Sci Rep 15(1):37557
| C. albicans | |ALS1 |ALS3 |HWP1 |
Zaffran I, et al. (2025) Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis. Nat Commun 16(1):9291
| C. albicans | |ALS5 |ALS6 |ALS7 |ECE1 |
Zhang L, et al. (2025) Proteomics and beta-hydroxybutyrylome reveal the novel mechanisms underlying fluconazole resistance in Candida albicans. Future Microbiol :1-11
| C. albicans | |CDC19 |ERG10 |HDA1 |MSI3 |RTT109 |
Return to CGD